Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations

被引：2

作者：

Arellano, Felix M. ^{[1
,2
]}

Yood, Marianne Ulcickas ^{[3
]}

Wentworth, Charles E. ^{[1
]}

Oliveria, Susan A. ^{[3
,4
]}

Rivero, Elena ^{[5
]}

Arana, Alejandro

Rothman, Kenneth T.

机构：

[1] Risk Management Resources, Bridgewater, NJ USA

[2] Risk Management Resources Espana, Zaragoza, Spain

[3] EpiSource, Hamden, CT USA

[4] Cornell Univ, Weill Med Coll, Ithaca, NY 14853 USA

[5] Novartis Farmaceut, Barcelona, Spain

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2008年 / 17卷 / 10期

关键词：

D O I：

10.1002/pds.1636

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 [公共卫生与预防医学]; 120402 [社会医学与卫生事业管理];

摘要：

引用

页码：1037 / 1037

页数：1

共 4 条

[1]

Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile [J].

Arellano, Felix M. ;

Yood, Marianne Ulcickas ;

Wentworth, Charles E. ;

Oliveria, Susan A. ;

Rivero, Elena ;

Verma, Anila ;

Rothman, Kenneth J. .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 (12) :861-872

[2]

Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population [J].

Garcia Rodriguez, Luis A. ;

Tolosa, Laura Barreales .

GASTROENTEROLOGY, 2007, 132 (02) :498-506

[3]

Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research [J].

Lewis, James D. ;

Schinnar, Rita ;

Bilker, Warren B. ;

Wang, Xingmei ;

Strom, Brian L. .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (04) :393-401

[4]

Re: Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations: implications for COX-2 cardiovascular profile [J].

van Staa, Tjeerd P. ;

Parkinson, J. .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (11) :1253-1254

← 1 →